A CME accredited programme to help with the diagnosis and treatment of hereditary angioedema (HAE)
|
|
|
|---|
|
|
|
|---|

HAE (hereditary angioedema) is a rare genetic disorder characterised by acute attacks of oedema.1 It affects between one in 10,000 – 50,000 people2 and is caused by a deficiency or dysfunction of the C1-inhibitor (C1-INH) protein.
Low awareness of this uncommon disorder and similarities between symptoms of HAE and other conditions means that diagnosis is often delayed – the average time from initial attack to diagnosis is thought to be around 13 years.3 Symptoms can significantly impact patients' quality of life,4 and if left untreated, may result in potentially fatal consequences.
It is for this reason that we have developed the HAE Awareness Programme. So why not complete the programme today, and learn more about HAE and how to improve the standards of care for your patients who have (or potentially have) this disease.
Dr Hilary Longhurst
Chair, Editorial Board
Images reproduced with the kind permission of the patient
Images reproduced with the kind permission of the patient

